Asthma prevention in newborns: a game-changer for childhood health
Asthma, a common childhood condition, may have a surprising link to early viral infections. Belgian scientists, in collaboration with Danish partners, have uncovered a compelling connection between respiratory syncytial virus (RSV) and the development of asthma in children. This discovery could revolutionize our approach to asthma prevention.
But here's where it gets controversial: the research suggests that protecting newborns from RSV could significantly reduce asthma rates later in life. And this is the part most people miss - the potential impact of this finding on families and healthcare systems.
Understanding the Asthma Puzzle
Asthma affects 5-15% of European children, impacting their daily lives and placing a heavy burden on families and society. It's a complex disease with various contributing factors, and researchers have been searching for ways to reduce asthma risk before symptoms even begin.
Prof. Bart Lambrecht, from the VIB-UGent Center for Inflammation Research, explains, "Childhood asthma is a complex web of factors, and we've found that early RSV infection and genetic allergy risk interact in a unique way that leads to asthma. The good news? It's preventable."
The RSV-Allergy Connection
To explore this relationship, the team combined nationwide health data from Denmark with controlled lab studies. They discovered that severe RSV infections in infancy can amplify the impact of inherited allergy risk.
Infants who experience severe RSV infections are more likely to develop immune responses that overreact to common allergens like house dust mites. This tendency is further exacerbated when asthma or allergies run in the family, as allergen-specific antibodies passed from parents to newborns increase sensitivity.
Prevention: A Game-Changer
A crucial finding was that protecting newborns from RSV in experimental models completely prevented these immune system shifts, and as a result, asthma did not develop. Prof. Hamida Hammad, co-senior author, emphasizes, "With accessible RSV prevention methods, we can improve long-term respiratory health, not just prevent RSV hospitalizations. It's a powerful message for parents."
Maternal vaccination during the third trimester and passive immunization of newborns are effective strategies being implemented in many countries. However, uptake has been inconsistent, despite their proven ability to prevent RSV hospitalizations.
A Call to Action
Lambrecht adds, "This is a unique opportunity for policy, science, and pediatricians to unite. If preventing RSV infection reduces asthma risk, the benefits for families and healthcare systems are immense."
This research was supported by the European Research Council, the University of Ghent, and Research Foundation - Flanders (FWO), highlighting the importance of this discovery.
